Tubeimoside III inhibits
lipopolysaccharide-induced inflammatory responses by reprogramming
glycolytic metabolism
Yushi Lina,b, ✝, Hongyi
Yuea,b, ✝,Pingyi
Wang a,b,Yimei
Lia,b,Dan Song a ,b,*,Wenhua
Li a,b,*
Engineering Research Center of Tibetan Medicine Detection Technology,
Ministry of Education, School of Medicine, Xizang Minzu University,
Xianyang 712082, Shaanxi, China.
Key Laboratory for Molecular Genetic Mechanisms and Intervention
Research on High Altitude Disease of Tibet Autonomous Region, School
of Medicine, Xizang Minzu University, Xianyang 712082, Shaanxi, China.
✝.Yushi Lin and Hongyi Yue have contributed equally to this work and
share first authorship.
*. Correspondence to: School of Medicine, Xizang Minzu University,
Xianyang 712082, China. E-mail address: xzmylwh@163.com (Wenhua Li),
dsong@xzmu.edu.cn (Dan Song).